Bentham Science Logo
Journal Cover

Track Your Manuscript:


Recent Patents on Anti-Cancer Drug Discovery

Volume 16, 4 Issues, 2021
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access

Aims & Scope

Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.

Recent Patents on Anti-Cancer Drug Discovery

,

Volume 16

-

Number 1



Preface   Open Access

Preface

, 16(1): e242403032121192442

Zhe-Sheng (Jason) Chen


DOI: 10.2174/157489281601210324142034


Biography   Open Access











Research Article



Research Article



Articles Ahead of Print

STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells


Yao Liu, Xiaolin Peng, Hui Li, Wenhui Jiao, Xin Peng, Jingrong Shao, Yanglu Xu, Ran Wang*, Wei Wang* and Dexin Kong*


DOI: 10.2174/1574892816666210224155403
View Abstract View on PubMed




Human Saliva Metabolome for Oral Lichen Planus Biomarker Identification


Xiaoshuang Wang, Liwei Liu, Qiuzheng Du, Zhi Sun, Erli Yue, Peng Xue* and Hongyu Zhao*


DOI: 10.2174/1574892816666210224160120
View Abstract View on PubMed







Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of Cannabis sativa in Breast Cancer


Babatomiwa Kikiowo*, Adewale J. Ogunleye, Opeyemi Iwaloye, Taiwo T. Ijatuyi, Niyi S . Adelakun and Wasiu O. Alashe


DOI: 10.2174/1574892816666210201115359
View Abstract View on PubMed


Abstracts Ahead of Print


Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review


Zainab Sabry Othman Ahmed, Matthew Golovoy, Yassen Abdullah, Reda Saber Ibrahim Ahmed and Q. Ping Dou*


DOI: 10.2174/1574892816666210615163417
View Abstract








A link between chemical structure and biological activity in triterpenoids


Li Zang, Hao Xu, Chao Huang, Cunqin Wang*, Rongbin Wang*, Ying Chen, Lei Wang and Hongting Wang*


DOI: 10.2174/1574892816666210512031635
View Abstract



Published Contents

Editor's Choice





Feasibility of Repurposing Clioquinol for Cancer Therapy

, 2020; 15(1): 14 - 31

Raheel Khan, Harras Khan, Yassen Abdullah and Q. Ping Dou*


DOI: 10.2174/1574892815666200227090259




HMGA and Cancer: A Review on Patent Literatures

, 2019; 14(3): 258 - 267

Marco De Martino, Alfredo Fusco and Francesco Esposito*


DOI: 10.2174/1574892814666190919152001




Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents

, 2019; 14(1): 5 - 18

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*


DOI: 10.2174/1574892814666190116111827



PARP Inhibitors in Ovarian Cancer

, 2018; 13(4): 392 - 410

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*


DOI: 10.2174/1574892813666180305165256



Open Access Articles


From Antimicrobial to Anticancer Peptides: The Transformation of Peptides

, 2019; 14(1): 70 - 84

Yuan Qin, Zuo D. Qin, Jing Chen, Che G. Cai, Ling Li, Lu Y. Feng, Zheng Wang, Gregory J. Duns, Nong Y. He, Zhe S. Chen* and Xiao F. Luo*





New Anti-Cancer Strategies in Testicular Germ Cell Tumors

, 2019; 14(1): 53 - 59

Paolo Chieffi*, Marco De Martino and Francesco Esposito




Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents

, 2019; 14(1): 5 - 18

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*




Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer

, 2019; 14(1): 39 - 52

Alessia Santoro, Carlo Tomino, Giulia Prinzi, Palma Lamonaca, Vittorio Cardaci, Massimo Fini and Patrizia Russo*




Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment

, 2019; 14(1): 32 - 38

Giorgia Scarpellino, Tullio Genova and Luca Munaron*




Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds

, 2019; 14(1): 19 - 31

Darinka G. Ackova, Katarina Smilkov and Darko Bosnakovski*




Semi-Synthetic Derivatives of Heliomycin with an Antiproliferative Potency

, 2018; 13(4): 469 - 472

Georgy Y. Nadysev, Alexander S. Tikhomirov, Lyubov G. Dezhenkova and Andrey E. Shchekotikhin*





Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature

, 2018; 13(4): 422 - 427

Sara Petrillo, Emanuela Tolosano, Luca Munaron and Tullio Genova*




Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options

, 2018; 13(2): 209 - 223

Theodosis Kalamatianos, Despoina Denekou, George Stranjalis and Evangelia Papadimitriou*




Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied

, 2018; 13(2): 201 - 208

Silvia M. Ferrari, Ilaria Ruffilli, Marco Centanni, Camilla Virili, Gabriele Materazzi, Magdalini Alexopoulou, Mario Miccoli, Alessandro Antonelli* and Poupak Fallahi




Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184 - 200

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*




PARP Inhibitors in Epithelial Ovarian Cancer

, 2018; 13(2): 145 - 158

Kristin N. Taylor and Ramez N. Eskander*





Most Cited Articles

Review Article

Repurposing disulfiram as an anti-cancer agent: Updated review on literature and patents

, 2019; 14(2): 113-132.

Elmira Ekinci, Sagar Rohondia, Raheel Khan and Qingping P. Dou*


DOI: 10.2174/1574892814666190514104035


Review Article

Tobacco smoking: Risk to develop addiction, chronic obstructive pulmonary disease, and lung cancer

, 2019; 14(1): 39-52.

Alessia Santoro, Carlo Tomino, Giulia Prinzi, Palma Lamonaca, Vittorio Cardaci, Massimo Fini and Patrizia Russo*


DOI: 10.2174/1574892814666190102122848


General Review Article

HMGA and cancer: A review on patent literatures

, 2019; 14(3): 258-267.

Marco De Martino, Alfredo Fusco and Francesco Esposito*


DOI: 10.2174/1574892814666190919152001


Review Article

Cucurbitacins as anticancer agents: A patent review

, 2019; 14(2): 133-143.

Hidayat Hussain*, Ivan R. Green, Muhammad Saleem, Khanzadi F. Khattak, Muhammad Irshad and Maroof Ali


DOI: 10.2174/1574892813666181119123035


Review Article

New anti-cancer strategies in testicular germ cell tumors

, 2019; 14(1): 53-59.

Paolo Chieffi*, Marco De Martino and Francesco Esposito


DOI: 10.2174/1574892814666190111120023


Research Article

A truncated snail1 transcription factor alters the expression of essential EMT markers and suppresses tumor cell migration in a human lung cancer cell line

, 2019; 14(2): 158-169.

Mohammad Davoodzadeh Gholami, Reza Falak*, Sahel Heidari, Majid Khoshmirsafa, Mohammad H. Kazemi, Amir-Hassan Zarnani, Elaheh Safari, Nader Tajik and Gholam A. Kardar*


DOI: 10.2174/1574892814666190527111429


Review Article

Tocotrienols and cancer: From the state of the art to promising novel patents

, 2019; 14(1): 5-18.

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*


DOI: 10.2174/1574892814666190116111827




Review Article

From antimicrobial to anticancer peptides: The transformation of peptides

, 2019; 14(1): 70-84.

Yuan Qin, Zuo D. Qin, Jing Chen, Che G. Cai, Ling Li, Lu Y. Feng, Zheng Wang, Gregory J. Duns, Nong Y. He, Zhe S. Chen* and Xiao F. Luo*


DOI: 10.2174/1574892814666190119165157


Review Article

Contemporary formulations for drug delivery of anticancer bioactive compounds

, 2019; 14(1): 19-31.

Darinka G. Ackova, Katarina Smilkov and Darko Bosnakovski*


DOI: 10.2174/1574892814666190111104834


Review Article

Purinergic P2X7 receptor: A cation channel sensitive to tumor microenvironment

, 2019; 14(1): 32-38.

Giorgia Scarpellino, Tullio Genova and Luca Munaron*


DOI: 10.2174/1574892814666190116122256


Review Article (Mini-Review)

Alkaloids as anticancer agents: A review of chinese patents in recent 5 years

, 2020; 15(1): 2-13.

Hongyu Tao, Ling Zuo, Huanli Xu, Cong Li, Gan Qiao, Mingyue Guo and Xiukun Lin*


DOI: 10.2174/1574892815666200131120618


Review Article

MDM2-P53 interaction inhibitors: The current state-of-art and updated patent review (2010-present)

, 2019; 14(4): 324-369.

Rafał Rusiecki, Jakub Witkowski* and Jaszczewska-Adamczak Joanna


DOI: 10.2174/1574892814666191022163540




Most Accessed Articles

Cancer Stem Cells and their Management in Cancer Therapy

, 2020; 15(3): 212-227.

Suzan Shenouda, Ketan Kulkarni, Yasser Abuetabh and Consolato Sergi *


DOI: 10.2174/1574892815666200713145931



Anti-Cancer Effect of Melatonin via Downregulation of Delta-like Ligand 4 in Estrogen-Responsive Breast Cancer Cells

, 2020; 15(4): 329-340.

Ali Rajabi, Ali Saber, Mahsa Pourmahdi, Ali Emami, Reyhaneh Ravanbakhsh, Amir Khodavirdipour, Mehran Khodaei, Molood Akbarzadeh, Sepehr Abdolahi, Mohammad Ali Hosseinpourfeizi and Reza Safaralizadeh*


DOI: 10.2174/1574892815666200929145236










Autophagy and Ubiquitination as Two Major Players in Colorectal Cancer: A Review on Recent Patents

, 2020; 15(2): 143-153.

Javad Saffari-Chaleshtori, Majid Asadi-Samani, Maryam Rasouli and Sayed Mohammad Shafiee*


DOI: 10.2174/1574892815666200630103626




The JPJDF has Synergistic Effect with Fluoropyrimidine in the Maintenance Therapy for Metastatic Colorectal Cancer

, 2020; 15(3): 257-269.

Xiaoling Fu*, Yanbo Zhang, Lisheng Chang, Dengcheng Hui, Ru Jia, Ningning Liu, Huayue Zhang, Gang Han, Zhifen Han, Yuan Li, Hui Liu, Huirong Zhu and Qi Li*


DOI: 10.2174/1574892815666200717141205




Editor-in-Chief

graphic
Zhe-Sheng (Jason) Chen
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY
(USA)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Recent Patents on Anti-Cancer Drug Discovery was launched in 2006. Prof. Zhe-Sheng (Jason) Chen serves as the Editor-in-Chief of the journal.

Advertisement

webinar-june-21June-2021-ban

Related Journals

Related eBooks

eBooks Catalog